Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127800251 | 12780025 | 1 | I | 20160823 | 20160926 | 20160926 | EXP | US-ROCHE-1834266 | ROCHE | 66.00 | YR | F | Y | 97.00000 | KG | 20160926 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127800251 | 12780025 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 1?OVER 30-90 MINUTES ON DAY 1 | U | 125085 | |||||||||
| 127800251 | 12780025 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 2 | U | 125085 | 1650 | MG | |||||||
| 127800251 | 12780025 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 3 | U | 125085 | 1650 | MG | |||||||
| 127800251 | 12780025 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 4 | U | 125085 | 1650 | MG | |||||||
| 127800251 | 12780025 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 5 | U | 125085 | 1650 | MG | |||||||
| 127800251 | 12780025 | 6 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 6 | U | 125085 | 1650 | MG | |||||||
| 127800251 | 12780025 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 7 | U | 125085 | 1650 | MG | |||||||
| 127800251 | 12780025 | 8 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 8 | U | 125085 | 1650 | MG | |||||||
| 127800251 | 12780025 | 9 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | COURSE 9 | U | 125085 | 1650 | MG | |||||||
| 127800251 | 12780025 | 10 | SS | IXABEPILONE | IXABEPILONE | 1 | Intravenous (not otherwise specified) | COURSE 1 ?OVER 1 HOUR | U | 0 | 60 | MG | |||||||
| 127800251 | 12780025 | 11 | SS | IXABEPILONE | IXABEPILONE | 1 | Intravenous (not otherwise specified) | COURSE 2 | U | 0 | 60 | MG | |||||||
| 127800251 | 12780025 | 12 | SS | IXABEPILONE | IXABEPILONE | 1 | Intravenous (not otherwise specified) | COURSE 3 | U | 0 | 60 | MG | |||||||
| 127800251 | 12780025 | 13 | SS | IXABEPILONE | IXABEPILONE | 1 | Intravenous (not otherwise specified) | COURSE 4 | U | 0 | 60 | MG | |||||||
| 127800251 | 12780025 | 14 | SS | IXABEPILONE | IXABEPILONE | 1 | Intravenous (not otherwise specified) | COURSE 5 | U | 0 | 60 | MG | |||||||
| 127800251 | 12780025 | 15 | SS | IXABEPILONE | IXABEPILONE | 1 | Intravenous (not otherwise specified) | COURSE 6 | U | 0 | 60 | MG | |||||||
| 127800251 | 12780025 | 16 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | OVER 30 MINUTES | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127800251 | 12780025 | 1 | Papillary serous endometrial carcinoma |
| 127800251 | 12780025 | 10 | Papillary serous endometrial carcinoma |
| 127800251 | 12780025 | 16 | Papillary serous endometrial carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127800251 | 12780025 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127800251 | 12780025 | Anaemia | |
| 127800251 | 12780025 | Hypertension | |
| 127800251 | 12780025 | Neutrophil count decreased | |
| 127800251 | 12780025 | Platelet count decreased | |
| 127800251 | 12780025 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127800251 | 12780025 | 1 | 20111121 | 0 | ||
| 127800251 | 12780025 | 2 | 20111212 | 0 | ||
| 127800251 | 12780025 | 3 | 20120102 | 0 | ||
| 127800251 | 12780025 | 4 | 20120123 | 0 | ||
| 127800251 | 12780025 | 5 | 20120213 | 0 | ||
| 127800251 | 12780025 | 6 | 20120305 | 0 | ||
| 127800251 | 12780025 | 7 | 20120416 | 0 | ||
| 127800251 | 12780025 | 8 | 20120507 | 0 | ||
| 127800251 | 12780025 | 9 | 20120528 | 0 | ||
| 127800251 | 12780025 | 10 | 20111121 | 0 | ||
| 127800251 | 12780025 | 11 | 20111212 | 0 | ||
| 127800251 | 12780025 | 12 | 20120102 | 0 | ||
| 127800251 | 12780025 | 13 | 20120123 | 0 | ||
| 127800251 | 12780025 | 14 | 20120213 | 0 | ||
| 127800251 | 12780025 | 15 | 20120305 | 0 |